DelNova
Highland, US · Founded 2016 · 1 known investors
Find your way into DelNova
170 people in our graph share verified history with the DelNova team — schools, employers, funds. One of them is your warm intro.
Rami Rahalunlockedknows Mary Gardner · together at McMaster University
×11knows the team · via McMaster University
DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
Founders & leadership
DelNova was founded in 2016 by Mary Gardner.
MG
Mary GardnerinCEO and FounderMary Gardner is the founder and CEO of DelNova, a life science company developing therapeutics in medical aesthetics and neuromuscular applications. She holds degrees from McMaster University and the University of Western Ontario and has extensive experience in pharmaceutical, biotechnology, and medical device sectors.
SB
Sameer B. ShahChief Scientist
SY
Steven YoelinChief Medical Strategist
DJ
Dimas JimenezChief Financial Advisor
Board
DB
Investors · 1
Reported raises · per SEC filings
Form D private placements$810.2K disclosed across 1 round · 2018
▶$810.2KraisedApr 2018 · 3 investors · OtherRule 506(b)
▶$810.2KraisedApr 2018 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BradburyDirector
- Mary GardnerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $810.2K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Teknova6 shared keywordsTeknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.
Grenova5 shared keywordsGrenova develops laboratory technology for washing and reusing pipette tips and microwell plates, aimed at labs seeking to reduce consumable waste and costs. The company operates in the life sciences lab equipment and sustainability space.
Companies competing with DelNova for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does DelNova do?
- DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
- Who founded DelNova?
- DelNova was founded by Mary Gardner in 2016.
- Who are DelNova's investors?
- DelNova's investors include BioBrit.
- How much funding has DelNova raised?
- DelNova has disclosed $810.2K raised across 1 round.
- Where is DelNova headquartered?
- DelNova is headquartered in Highland, US.